Investigating microRNA Profiles in Prostate Cancer Bone Metastases and Functional Effects of microRNA-23c and...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Prostate cancer (PC) progression involves aberrant microRNA (miRNA) expression.
• Knowledge of miRNA profiles in metastatic PC, particularly bone metastasis, remains limited.
• Understanding miRNA changes is crucial for identifying therapeutic targets.

Purpose of the Study:

• To investigate differential miRNA expression in prostate cancer bone metastases.
• To identify specific downregulated miRNAs during PC progression.
• To explore the functional impact of miRNA-23c and miRNA-4328 on PC growth.

Main Methods:

• Microarray screening of 1510 miRNAs in bone metastases, localized PC, and benign prostate tissues.
• Quantitative polymerase chain reaction (qPCR) to validate miRNA downregulation.
• In vitro cell line experiments (22Rv1, PC-3) to assess miRNA overexpression effects.
• In vivo mouse models to evaluate tumor suppressive effects.

Main Results:

• Significant differential expression of miRNAs observed, with 75 decreased and 4 increased (p < 0.05).
• Consistent downregulation of specific miRNAs (e.g., miRNA-1, -23c, -143-3p, -4328) during progression from benign to metastatic PC.
• Overexpression of miRNA-23c and -4328 reduced PC cell growth in vitro, with miRNA-23c secreted in extracellular vesicles.
• No significant tumor suppressive effect of miRNA-23c was observed in vivo.

Conclusions:

• Prostate cancer bone metastases exhibit a marked reduction in miRNA levels.
• Downregulation of miRNAs, including miRNA-23c and -4328, correlates with disease progression and potential loss of tumor suppressive functions.
• These miRNAs represent potential biomarkers and therapeutic targets for advanced prostate cancer.